These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16354241

  • 1. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients.
    Labonia W, Rubio D, Arias C.
    Nephrology (Carlton); 2005 Dec; 10(6):583-7. PubMed ID: 16354241
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 5. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 6. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y, Nakayama M, Yoshimura K, Nakano H, Yamamoto H, Yokoyama K, Lindholm B.
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [Abstract] [Full Text] [Related]

  • 7. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 May; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Sunder-Plassmann G, Hörl WH.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
    [Abstract] [Full Text] [Related]

  • 11. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S, Safárová R, Horácková M, Herink J, Rychlík I, Bahbouh R, Půtová I.
    Cas Lek Cesk; 2001 Apr 12; 140(7):209-13. PubMed ID: 11374225
    [Abstract] [Full Text] [Related]

  • 12. Intravenous iron dextran treatment in predialysis patients with chronic renal failure.
    Dahdah K, Patrie JT, Bolton WK.
    Am J Kidney Dis; 2000 Oct 12; 36(4):775-82. PubMed ID: 11007680
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S, Cropper L, Mostafa S, Turner J, Bailey G, Pugh-Clarke K.
    J Ren Care; 2008 Sep 12; 34(3):112-5. PubMed ID: 18786076
    [Abstract] [Full Text] [Related]

  • 15. Intravenous iron supplementation in children on hemodialysis.
    Leijn E, Monnens LA, Cornelissen EA.
    J Nephrol; 2004 Sep 12; 17(3):423-6. PubMed ID: 15365964
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.